Advertisement
U.S. Markets closed

Genscript Biotech Corporation (1548.HK)

HKSE - HKSE Delayed Price. Currency in HKD
11.800-0.300 (-2.48%)
At close: 04:08PM HKT
Advertisement
Show:
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
839,529
839,529
625,698
490,096
390,846
-
Cost of Revenue
429,976
429,976
321,615
207,578
134,953
-
Gross Profit
409,553
409,553
304,083
282,518
255,893
-
Operating Expense
808,623
808,623
731,839
651,730
447,886
-
Operating Income
-399,070
-399,070
-427,756
-369,212
-191,993
-
Net Non Operating Interest Income Expense
45,676
45,676
-51
407
-1,134
-
Pretax Income
-350,979
-350,979
-431,690
-517,363
-281,900
-
Tax Provision
4,142
4,142
-3,719
964
-477
-
Net Income Common Stockholders
-95,477
-95,477
-226,851
-358,712
-204,945
-
Diluted NI Available to Com Stockholders
-95,477
-95,477
-226,851
-358,712
-204,945
-
Basic EPS
-0.09
-
-0.11
-0.18
-0.11
-0.05
Diluted EPS
-0.09
-
-0.11
-0.18
-0.11
-0.05
Basic Average Shares
2,105,161
-
2,097,135
2,030,598
1,900,787
1,853,927
Diluted Average Shares
2,105,161
-
2,097,135
2,030,598
1,900,787
1,853,927
Rent Expense Supplemental
4,401
-
-
-
-
-
Total Expenses
1,238,599
1,238,599
1,053,454
859,308
582,839
-
Net Income from Continuing & Discontinued Operation
-95,477
-95,477
-226,851
-358,712
-204,945
-
Normalized Income
-118,739
-118,739
-232,938
-259,141
-211,075
-
Interest Income
73,186
73,186
13,218
2,785
4,298
-
Interest Expense
27,510
27,510
13,269
2,378
1,418
-
Net Interest Income
45,676
45,676
-51
407
-1,134
-
EBIT
-323,469
-323,469
-418,421
-514,985
-280,482
-
EBITDA
-249,423
-249,423
-354,173
-467,206
-247,587
-
Reconciled Cost of Revenue
429,976
429,976
321,615
207,578
134,953
-
Reconciled Depreciation
74,046
74,046
64,248
47,779
32,895
-
Net Income from Continuing Operation Net Minority Interest
-95,477
-95,477
-226,851
-358,712
-204,945
-
Total Unusual Items Excluding Goodwill
29,445
29,445
6,140
-136,398
6,140
-
Total Unusual Items
29,445
29,445
6,140
-136,398
6,140
-
Normalized EBITDA
-278,868
-278,868
-360,313
-330,808
-253,727
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
6,183
6,183
52.896
-36,827
10.3894
-